{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "02", "@year": "2019", "@timestamp": "2019-11-02T09:28:20.000020-04:00", "@month": "11"}, "ait:date-sort": {"@day": "01", "@year": "2013", "@month": "12"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding-addon-generated-timestamp": "2021-05-10T21:26:23.332794Z", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"city-group": "Bangkok 10330", "country": "Thailand", "@afid": "60028190", "@country": "tha", "organization": [{"$": "Gynecologic Oncology Division"}, {"$": "Department of Obstetrics and Gynecology"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113356767"}, "@dptid": "113356767"}, "author": [{"ce:given-name": "Tarinee", "preferred-name": {"ce:given-name": "Tarinee", "ce:initials": "T.", "ce:surname": "Manchana", "ce:indexed-name": "Manchana T."}, "@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Manchana", "@auid": "12244640600", "ce:indexed-name": "Manchana T."}]}, {"author": [{"ce:given-name": "Punnada", "preferred-name": {"ce:given-name": "Punnada", "ce:initials": "P.", "ce:surname": "Athibovonsuk", "ce:indexed-name": "Athibovonsuk P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Athibovonsuk", "@auid": "55883391600", "ce:indexed-name": "Athibovonsuk P."}, {"ce:given-name": "Nakarin", "preferred-name": {"ce:given-name": "Nakarin", "ce:initials": "N.", "ce:surname": "Sirisabya", "ce:indexed-name": "Sirisabya N."}, "@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Sirisabya", "@auid": "12244914100", "ce:indexed-name": "Sirisabya N."}]}], "citation-title": "Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy", "abstracts": "Objectives To compare the efficacy of intravenous iron and oral iron for prevention of blood transfusions in gynecologic cancer patients receiving platinum-based chemotherapy. Materials and methods Sixty-four non anemic gynecologic cancer patients receiving adjuvant platinum-based chemotherapy were stratified and randomized according to baseline hemoglobin levels and chemotherapy regimen. The study group received 200 mg of intravenous iron sucrose immediately after each chemotherapy infusion. The control group received oral ferrous fumarate at a dose of 200 mg three times a day. Complete blood count was monitored before each chemotherapy infusion. Blood transfusions were given if hemoglobin level was below 10 mg/dl. Results There were 32 patients in each group. No significant differences in baseline hemoglobin levels and baseline characteristics were demonstrated between both groups. Nine patients (28.1%) in the study group and 18 patients (56.3%) in the control group required blood transfusion through 6 cycles of chemotherapy (p = 0.02). Fewer median number of total packed red cell units were required in the study group compared to the control group (0 and 0.5 unit, respectively, p = 0.04). Serious adverse events and hypersensitivity reactions were not reported. However, constipation was significantly higher in the control group (3.1% and 40.6%, p = < 0.001). Conclusions Intravenous iron is an effective, well-tolerated treatment for primary prevention of blood transfusions in gynecologic cancer patients receiving platinum-based chemotherapy, associated with less constipation than the oral formulation. \u00a9 2013 Elsevier Inc.", "correspondence": {"affiliation": {"city-group": "Bangkok 10330", "country": "Thailand", "@country": "tha", "organization": [{"$": "Gynecologic Oncology Division"}, {"$": "Department of Obstetrics and Gynecology"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:initials": "T.", "ce:surname": "Manchana", "ce:indexed-name": "Manchana T."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Anemia", "@xml:lang": "eng"}, {"$": "Blood transfusion", "@xml:lang": "eng"}, {"$": "Chemotherapy", "@xml:lang": "eng"}, {"$": "Gynecologic cancer", "@xml:lang": "eng"}, {"$": "Intravenous iron", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"codencode": "GYNOA", "sourcetitle-abbrev": "Gynecol. Oncol.", "@country": "usa", "issn": [{"$": "00908258", "@type": "print"}, {"$": "10956859", "@type": "electronic"}], "volisspag": {"voliss": {"@volume": "131", "@issue": "3"}, "pagerange": {"@first": "679", "@last": "682"}}, "@type": "j", "publicationyear": {"@first": "2013"}, "sourcetitle": "Gynecologic Oncology", "@srcid": "27467", "publicationdate": {"month": "12", "year": "2013", "date-text": {"@xfab-added": "true", "$": "December 2013"}}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": {"classification-code": "87.4.1", "classification-description": "CANCER RESEARCH; TREATMENT; Chemotherapy"}}, {"@type": "EMCLASS", "classification": [{"classification-code": "10.3", "classification-description": "Obstetrics and Gynecology; GYNECOLOGY"}, {"classification-code": "16", "classification-description": "Cancer"}, {"classification-code": "25.3.1", "classification-description": "Hematology; TREATMENT; Transfusion, apheresis and dialysis"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38.35", "classification-description": "Adverse Reactions Titles; BLOOD AND BLOOD DERIVATIVES"}]}, {"@type": "ASJC", "classification": [{"$": "2730"}, {"$": "2729"}]}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "tradenamegroup": {"tradenames": {"trademanuitem": {"tradename": "venofer", "manufacturer": {"@country": "tha", "$": "dksh limited"}}, "@type": "TNM"}}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "41575-94-4", "chemical-name": "carboplatin"}, {"cas-registry-number": [{"$": "141-01-5"}, {"$": "7705-12-6"}], "chemical-name": "ferrous fumarate"}, {"cas-registry-number": "9008-02-0", "chemical-name": "hemoglobin"}, {"cas-registry-number": [{"$": "63530-05-2"}, {"$": "8047-67-4"}], "chemical-name": "iron saccharate"}, {"cas-registry-number": "33069-62-4", "chemical-name": "paclitaxel"}]}, {"@source": "nlm", "chemical": [{"cas-registry-number": "BG3F62OND5", "chemical-name": "Carboplatin"}, {"cas-registry-number": "0", "chemical-name": "Ferric Compounds"}, {"cas-registry-number": "QLZ991V4A2", "chemical-name": "Glucaric Acid"}, {"cas-registry-number": "0", "chemical-name": "Hematinics"}, {"cas-registry-number": "0", "chemical-name": "Hemoglobins"}, {"cas-registry-number": "33069-62-4", "chemical-name": "Paclitaxel"}, {"cas-registry-number": "8047-67-4", "chemical-name": "ferric oxide, saccharated"}]}]}, "manufacturergroup": {"manufacturers": {"@type": "MNF", "manufacturer": {"@country": "tha", "$": "dksh limited"}}}}}, "item-info": {"copyright": [{"$": "Copyright 2014 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, {"$": "MEDLINE\u00ae is the source for the MeSH terms of this document.", "@type": "Medline Descriptors"}], "dbcollection": [{"$": "EMBASE"}, {"$": "CABS"}, {"$": "MOSYEA"}, {"$": "MEDL"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "21", "@year": "2013", "@month": "10"}}, "itemidlist": {"itemid": [{"$": "52821165", "@idtype": "PUI"}, {"$": "2013744410", "@idtype": "EMBASE"}, {"$": "2013361932", "@idtype": "CABS"}, {"$": "2013134063", "@idtype": "MOSYEA"}, {"$": "24099839", "@idtype": "MEDL"}, {"$": "84888301208", "@idtype": "SCP"}, {"$": "84888301208", "@idtype": "SGR"}], "ce:pii": "S009082581301202X", "ce:doi": "10.1016/j.ygyno.2013.09.028"}}, "tail": {"bibliography": {"@refcount": "12", "reference": [{"ref-fulltext": "H. Ludwig, S. Van Belle, P. Barrett-Lee, G. Birgegard, C. Bokemeyer, and P. Gascon The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients Eur J Cancer 40 2004 2293 2306", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients"}, "refd-itemidlist": {"itemid": {"$": "5344263788", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "40"}, "pagerange": {"@first": "2293", "@last": "2306"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Ludwig", "ce:indexed-name": "Ludwig H."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Van Belle", "ce:indexed-name": "Van Belle S."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Barrett-Lee", "ce:indexed-name": "Barrett-Lee P."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Birgegard", "ce:indexed-name": "Birgegard G."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Bokemeyer", "ce:indexed-name": "Bokemeyer C."}, {"@seq": "6", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Gascon", "ce:indexed-name": "Gascon P."}]}, "ref-sourcetitle": "Eur J Cancer"}}, {"ref-fulltext": "G. Birgegard, M.S. Aapro, C. Bokemeyer, M. Dicato, P. Drings, and J. Hornedo Cancer-related anemia: pathogenesis, prevalence and treatment Oncology 68 2005 3 11", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Cancer-related anemia: Pathogenesis, prevalence and treatment"}, "refd-itemidlist": {"itemid": {"$": "20844434968", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "68"}, "pagerange": {"@first": "3", "@last": "11"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Birgegard", "ce:indexed-name": "Birgegard G."}, {"@seq": "2", "ce:initials": "M.S.", "@_fa": "true", "ce:surname": "Aapro", "ce:indexed-name": "Aapro M.S."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Bokemeyer", "ce:indexed-name": "Bokemeyer C."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Dicato", "ce:indexed-name": "Dicato M."}, {"@seq": "5", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Drings", "ce:indexed-name": "Drings P."}, {"@seq": "6", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Hornedo", "ce:indexed-name": "Hornedo J."}]}, "ref-sourcetitle": "Oncology"}}, {"ref-fulltext": "J.E. Groopman, and L.M. Itri Chemotherapy-induced anemia in adults: incidence and treatment J Natl Cancer Inst 91 1999 1616 1634", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "Chemotherapy-induced anemia in adults: Incidence and treatment"}, "refd-itemidlist": {"itemid": {"$": "0033530262", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "91"}, "pagerange": {"@first": "1616", "@last": "1634"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.E.", "@_fa": "true", "ce:surname": "Groopman", "ce:indexed-name": "Groopman J.E."}, {"@seq": "2", "ce:initials": "L.M.", "@_fa": "true", "ce:surname": "Itri", "ce:indexed-name": "Itri L.M."}]}, "ref-sourcetitle": "J Natl Cancer Inst"}}, {"ref-fulltext": "M. Auerbach, H. Ballard, J.R. Trout, M. McIlwain, A. Ackerman, and H. Bahrain Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial J Clin Oncol 22 2004 1301 1307", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial"}, "refd-itemidlist": {"itemid": {"$": "2142825053", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "22"}, "pagerange": {"@first": "1301", "@last": "1307"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Auerbach", "ce:indexed-name": "Auerbach M."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Ballard", "ce:indexed-name": "Ballard H."}, {"@seq": "3", "ce:initials": "J.R.", "@_fa": "true", "ce:surname": "Trout", "ce:indexed-name": "Trout J.R."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "McIlwain", "ce:indexed-name": "McIlwain M."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Ackerman", "ce:indexed-name": "Ackerman A."}, {"@seq": "6", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Bahrain", "ce:indexed-name": "Bahrain H."}]}, "ref-sourcetitle": "J Clin Oncol"}}, {"ref-fulltext": "T. Tonia, A. Mettler, N. Robert, G. Schwarzer, J. Seidenfeld, and O. Weingart Erythropoietin or darbepoetin for patients with cancer Cochrane Database Syst Rev 12 Dec 12 2012 CD003407", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Erythropoietin or darbepoetin for patients with cancer"}, "refd-itemidlist": {"itemid": {"$": "84874179389", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "003407"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Tonia", "ce:indexed-name": "Tonia T."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Mettler", "ce:indexed-name": "Mettler A."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Robert", "ce:indexed-name": "Robert N."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Schwarzer", "ce:indexed-name": "Schwarzer G."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Seidenfeld", "ce:indexed-name": "Seidenfeld J."}, {"@seq": "6", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Weingart", "ce:indexed-name": "Weingart O."}]}, "ref-sourcetitle": "Cochrane Database Syst Rev"}}, {"ref-fulltext": "Y.T. Kim, S.W. Kim, B.S. Yoon, H.J. Cho, E.J. Nahm, and S.H. Kim Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy Gynecol Oncol 105 2007 199 204", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy"}, "refd-itemidlist": {"itemid": {"$": "33947312849", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "105"}, "pagerange": {"@first": "199", "@last": "204"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.T.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim Y.T."}, {"@seq": "2", "ce:initials": "S.W.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim S.W."}, {"@seq": "3", "ce:initials": "B.S.", "@_fa": "true", "ce:surname": "Yoon", "ce:indexed-name": "Yoon B.S."}, {"@seq": "4", "ce:initials": "H.J.", "@_fa": "true", "ce:surname": "Cho", "ce:indexed-name": "Cho H.J."}, {"@seq": "5", "ce:initials": "E.J.", "@_fa": "true", "ce:surname": "Nahm", "ce:indexed-name": "Nahm E.J."}, {"@seq": "6", "ce:initials": "S.H.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim S.H."}]}, "ref-sourcetitle": "Gynecol Oncol"}}, {"ref-fulltext": "P. Dangsuwan, and T. Manchana Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy Gynecol Oncol 116 2010 522 525", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy"}, "refd-itemidlist": {"itemid": {"$": "75749138424", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "116"}, "pagerange": {"@first": "522", "@last": "525"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Dangsuwan", "ce:indexed-name": "Dangsuwan P."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Manchana", "ce:indexed-name": "Manchana T."}]}, "ref-sourcetitle": "Gynecol Oncol"}}, {"ref-fulltext": "G. Weiss, and L.T. Goodnough Anemia of chronic disease N Engl J Med 352 2005 1011 1023", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Anemia of chronic disease"}, "refd-itemidlist": {"itemid": {"$": "14744278436", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "352"}, "pagerange": {"@first": "1011", "@last": "1023"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Weiss", "ce:indexed-name": "Weiss G."}, {"@seq": "2", "ce:initials": "L.T.", "@_fa": "true", "ce:surname": "Goodnough", "ce:indexed-name": "Goodnough L.T."}]}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "K. Munstedt, M. Kovacic, M. Zygmunt, and R. Von Georgi Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer Int J Oncol 23 2003 837 843", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer"}, "refd-itemidlist": {"itemid": {"$": "7444223057", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "837", "@last": "843"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Munstedt", "ce:indexed-name": "Munstedt K."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Kovacic", "ce:indexed-name": "Kovacic M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Zygmunt", "ce:indexed-name": "Zygmunt M."}, {"@seq": "4", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Von Georgi", "ce:indexed-name": "Von Georgi R."}]}, "ref-sourcetitle": "Int J Oncol"}}, {"ref-fulltext": "A. Gafter-Gvili, B. Rozen-Zvi, L. Vidal, L. Leibovici, J. Vansteenkiste, and U. Gafter Intravenous iron supplementation for the treatment of chemotherapy induced anaemia-systematic review and meta-analysis of randomized controlled trials Acta Oncol 52 2013 18 29", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Intravenous iron supplementation for the treatment of chemotherapy induced anaemia-systematic review and meta-analysis of randomized controlled trials"}, "refd-itemidlist": {"itemid": {"$": "84871400455", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "52"}, "pagerange": {"@first": "18", "@last": "29"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Gafter-Gvili", "ce:indexed-name": "Gafter-Gvili A."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Rozen-Zvi", "ce:indexed-name": "Rozen-Zvi B."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Vidal", "ce:indexed-name": "Vidal L."}, {"@seq": "4", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Leibovici", "ce:indexed-name": "Leibovici L."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Vansteenkiste", "ce:indexed-name": "Vansteenkiste J."}, {"@seq": "6", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Gafter", "ce:indexed-name": "Gafter U."}]}, "ref-sourcetitle": "Acta Oncol"}}, {"ref-fulltext": "G.R. Bailie, J.A. Clark, C.E. Lane, and P.L. Lane Hypersensitivity reactions and deaths associated with intravenous iron preparations Nephrol Dial Transplant 20 2005 1443 1449", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Hypersensitivity reactions and deaths associated with intravenous iron preparations"}, "refd-itemidlist": {"itemid": {"$": "26044476338", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "1443", "@last": "1449"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.R.", "@_fa": "true", "ce:surname": "Bailie", "ce:indexed-name": "Bailie G.R."}, {"@seq": "2", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Clark", "ce:indexed-name": "Clark J.A."}, {"@seq": "3", "ce:initials": "C.E.", "@_fa": "true", "ce:surname": "Lane", "ce:indexed-name": "Lane C.E."}, {"@seq": "4", "ce:initials": "P.L.", "@_fa": "true", "ce:surname": "Lane", "ce:indexed-name": "Lane P.L."}]}, "ref-sourcetitle": "Nephrol Dial Transplant"}}, {"ref-fulltext": "E. Luporsi, L. Mahi, C. Morre, J. Wernli, G. de Pouvourville, and R. Bugat Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoieis-stimulating agents and blood transfusion: French healthcare payer perspective J Med Econ 15 2012 225 232", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoieis-stimulating agents and blood transfusion: French healthcare payer perspective"}, "refd-itemidlist": {"itemid": {"$": "84858129582", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "225", "@last": "232"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Luporsi", "ce:indexed-name": "Luporsi E."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Mahi", "ce:indexed-name": "Mahi L."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Morre", "ce:indexed-name": "Morre C."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Wernli", "ce:indexed-name": "Wernli J."}, {"@seq": "5", "ce:initials": "G.", "@_fa": "true", "ce:surname": "De Pouvourville", "ce:indexed-name": "De Pouvourville G."}, {"@seq": "6", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Bugat", "ce:indexed-name": "Bugat R."}]}, "ref-sourcetitle": "J Med Econ"}}]}}}}, "affiliation": {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, "coredata": {"srctype": "j", "eid": "2-s2.0-84888301208", "dc:description": "Objectives To compare the efficacy of intravenous iron and oral iron for prevention of blood transfusions in gynecologic cancer patients receiving platinum-based chemotherapy. Materials and methods Sixty-four non anemic gynecologic cancer patients receiving adjuvant platinum-based chemotherapy were stratified and randomized according to baseline hemoglobin levels and chemotherapy regimen. The study group received 200 mg of intravenous iron sucrose immediately after each chemotherapy infusion. The control group received oral ferrous fumarate at a dose of 200 mg three times a day. Complete blood count was monitored before each chemotherapy infusion. Blood transfusions were given if hemoglobin level was below 10 mg/dl. Results There were 32 patients in each group. No significant differences in baseline hemoglobin levels and baseline characteristics were demonstrated between both groups. Nine patients (28.1%) in the study group and 18 patients (56.3%) in the control group required blood transfusion through 6 cycles of chemotherapy (p = 0.02). Fewer median number of total packed red cell units were required in the study group compared to the control group (0 and 0.5 unit, respectively, p = 0.04). Serious adverse events and hypersensitivity reactions were not reported. However, constipation was significantly higher in the control group (3.1% and 40.6%, p = < 0.001). Conclusions Intravenous iron is an effective, well-tolerated treatment for primary prevention of blood transfusions in gynecologic cancer patients receiving platinum-based chemotherapy, associated with less constipation than the oral formulation. \u00a9 2013 Elsevier Inc.", "pubmed-id": "24099839", "prism:coverDate": "2013-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84888301208", "dc:creator": {"author": [{"ce:given-name": "Punnada", "preferred-name": {"ce:given-name": "Punnada", "ce:initials": "P.", "ce:surname": "Athibovonsuk", "ce:indexed-name": "Athibovonsuk P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Athibovonsuk", "@auid": "55883391600", "author-url": "https://api.elsevier.com/content/author/author_id/55883391600", "ce:indexed-name": "Athibovonsuk P."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84888301208"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84888301208&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84888301208&origin=inward"}], "source-id": "27467", "pii": "S009082581301202X", "citedby-count": "33", "prism:volume": "131", "subtype": "ar", "dc:title": "Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy", "openaccess": "0", "prism:issn": "00908258 10956859", "prism:issueIdentifier": "3", "subtypeDescription": "Article", "prism:publicationName": "Gynecologic Oncology", "prism:pageRange": "679-682", "prism:endingPage": "682", "openaccessFlag": "false", "prism:doi": "10.1016/j.ygyno.2013.09.028", "prism:startingPage": "679", "dc:identifier": "SCOPUS_ID:84888301208"}, "idxterms": {"mainterm": [{"$": "Anemia", "@weight": "b", "@candidate": "n"}, {"$": "Blood transfusion", "@weight": "b", "@candidate": "n"}, {"$": "Chemotherapy", "@weight": "b", "@candidate": "n"}, {"$": "Gynecologic cancer", "@weight": "b", "@candidate": "n"}, {"$": "Intravenous iron", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Anemia"}, {"@_fa": "true", "$": "Blood transfusion"}, {"@_fa": "true", "$": "Chemotherapy"}, {"@_fa": "true", "$": "Gynecologic cancer"}, {"@_fa": "true", "$": "Intravenous iron"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Oncology", "@code": "2730", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Obstetrics and Gynecology", "@code": "2729", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Punnada", "preferred-name": {"ce:given-name": "Punnada", "ce:initials": "P.", "ce:surname": "Athibovonsuk", "ce:indexed-name": "Athibovonsuk P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Athibovonsuk", "@auid": "55883391600", "author-url": "https://api.elsevier.com/content/author/author_id/55883391600", "ce:indexed-name": "Athibovonsuk P."}, {"ce:given-name": "Tarinee", "preferred-name": {"ce:given-name": "Tarinee", "ce:initials": "T.", "ce:surname": "Manchana", "ce:indexed-name": "Manchana T."}, "@seq": "2", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Manchana", "@auid": "12244640600", "author-url": "https://api.elsevier.com/content/author/author_id/12244640600", "ce:indexed-name": "Manchana T."}, {"ce:given-name": "Nakarin", "preferred-name": {"ce:given-name": "Nakarin", "ce:initials": "N.", "ce:surname": "Sirisabya", "ce:indexed-name": "Sirisabya N."}, "@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Sirisabya", "@auid": "12244914100", "author-url": "https://api.elsevier.com/content/author/author_id/12244914100", "ce:indexed-name": "Sirisabya N."}]}}}